主体防御的结构洞察力,免疫调节功能和治疗潜力,以避免抗菌素耐药性
Gisele Regina Rodrigues1, Michel Lopes Leite2, Octavio Luiz Franco2
1Centro de Análises Proteômicas e Bioquímicas, Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, DF, Brasília, Brazil.
主体防御 (HDPs) 为抗生素提供了一个有希望的替代品,用于打击抗菌素耐药性 (AMR). 它们独特的机制和与免疫受体的相互作用为开发有效的抗感染疗法提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益严重的全球卫生危机,使传统抗生素的效果变得不那么好.
- 治疗耐药细菌引起的感染是具有挑战性的,昂贵的,并且往往不成功.
- 主体防御 (HDPs) 是天生的免疫系统的关键组成部分,具有广泛的抗微生物和免疫调节活性.
研究的目的:
- 审查HDPs与免疫受体之间的复杂相互作用.
- 探索HDPs作为抗AMR的替代治疗策略的潜力.
- 为下一代抗感染疗法的发展提供信息.
主要方法:
- 文献综述侧重于HDPs,免疫受体 (PRRs如TLRs,NLRs,CLRs),以及它们在打击微生物感染中的作用.
- 分析HDP机制,包括直接杀死病原体和调节免疫反应.
- 检查HDPs临床应用的挑战和机会.
主要成果:
- HDPs具有直接的抗菌作用,并通过与模式识别受体 (PRR) 相互作用来调节先天免疫力.
- 这些相互作用导致微生物膜损伤,细胞因子生产,免疫细胞招募和白细胞迁移.
- 人类甲基素LL-37是具有杀死病原体和免疫调节能力的HDP的一个例子.
结论:
- 由于其独特的机制,HDPs代表了针对抗生素治疗AMR的可行替代品.
- 了解HDP-免疫受体相互作用对于克服AMR至关重要.
- 对HDPs的进一步研究可以指导新型抗感染治疗的开发.
更多相关视频
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
相关概念视频
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Structural Protein Function
Frustration and Conflict: Avoidance-Avoidance, Double-Approach Avoidance
Fruit Development, Structure, and Function
Peptide Bonds
Structure and Function of Erythrocytes
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
